|
"hsieh hp"的相關文件
顯示項目 241-265 / 265 (共6頁)
<< < 1 2 3 4 5 6 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2005-12-29 |
Novel indole-based peroxisome proliferator-activated receptor agonists: Design, SAR, structural biology, and biological activities
|
Mahindroo, N; Huang, CF; Peng, YH; Wang, CC; Liao, CC; Lien, TW; Chittimalla, SK; Huang, WJ; Chai, CH; Prakash, E; Chen, CP; Hsu, TA; Peng, CH; Lu, IL; Lee, LH; Chang, YW; Chen, WC; Chou, YC; Chen, CT; Goparaju, CMV; Chen, YS; Lan, SJ; Yu, MC; Chen, X; Chao, YS; Wu, SY; Hsieh, HP |
| 國家衛生研究院 |
2005-08-23 |
Indole compounds
|
Hsieh, HP;Liou, JP;Chang, JY;Chang, CW |
| 國家衛生研究院 |
2005-05 |
Shear stress inhibits smooth muscle cell-induced inflammatory gene expression in endothelial cells - Role of NF-kappa B
|
Chiu, JJ; Chang, SF; Lee, PL; Lee, CI; Tsai, MC; Lee, DY; Hsieh, HP; Usami, S; Chien, S |
| 國家衛生研究院 |
2005-05 |
Pharmaceutical design of antimitotic agents based on combretastatins
|
Hsieh, HP;Liou, JP;Mahindroo, N |
| 國家衛生研究院 |
2005-03 |
Promazine analogues as potential anti SARS-CoV drugs
|
Hsieh, HP;Wu, YS;Lu, PH;Chen, CM;Chao, YC;Jan, JT;Huei-Ru, L;Ma, SH;Chao, YS;Hsu, TA |
| 國家衛生研究院 |
2005-03 |
Design, synthesis and sar of indole-based PPAR agonists
|
Hsieh, HP;Mahindroo, N;Coumar, MS;Wang, CC;Huang, CF;Lien, TW;Tsai, CH;Lin, YT;Lee, LH;Prakash, E;Hsu, TA;Chen, X;Wu, SY;Chen, CT;Chao, YS |
| 國家衛生研究院 |
2005-03 |
Design and structure-activity relationships of novel indole-based PPAR agonists as antidiabetic agents
|
Hsieh, HP;Mahindroo, N;Wang, CC;Huang, CF;Lien, TW;Tsai, CH;Peng, YH;Lee, LH;Prakash, E;Chen, WC;Chang, YW;Hsu, TA;Chen, X;Wu, SY;Chen, CT;Lan, SJ;Chao, YS |
| 國家衛生研究院 |
2005 |
Inhibition of SARS-CoV 3C-like protease activity by theaflavin-3,3 '- digallate (TF3)
|
Chen, CN; Lin, CPC; Huang, KK; Chen, WC; Hsieh, HP; Liang, PH; Hsu, JTA |
| 國家衛生研究院 |
2004-09-10 |
Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV
|
Hsu, JTA; Kuo, CJ; Hsieh, HP; Wang, YC; Huang, KK; Lin, CPC; Huang, PF; Chen, X; Liang, PH |
| 國家衛生研究院 |
2004-09 |
Drug design of BPR0L075 as an anticancer agent
|
Hsieh, HP;Liou, JP;Chang, CW;Kuo, CC;Chang, YL;Kuo, FM;Tseng, HY;Pan, WY;Chen, CP;Yang, YN;Chen, CT;Lee, SJ;Chang, JY |
| 國家衛生研究院 |
2004-08-22 |
Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents
|
Hsieh, HP;Liou, JP;Chang, YL;Lee, SJ |
| 國家衛生研究院 |
2004-08-12 |
Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents
|
Liou, JP; Chang, YL; Kuo, FM; Chang, CW; Tseng, HY; Wang, CC; Yang, YN; Chang, JY; Lee, SJ; Hsieh, HP |
| 國家衛生研究院 |
2004-07-15 |
A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells
|
Juang, SH; Pan, WY; Kuo, CC; Liou, JP; Hung, YM; Chen, LT; Hsieh, HP; Chang, JY |
| 國家衛生研究院 |
2004-07-01 |
BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo
|
Kuo, CC; Hsieh, HP; Pan, WY; Chen, CP; Lion, JP; Lee, SJ; Chang, YL; Chen, LT; Chen, CT; Chang, JY |
| 國家衛生研究院 |
2004-07 |
Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide
|
Wu, CJ; Jan, JT; Chen, CM; Hsieh, HP; Hwang, DR; Liu, HW; Liu, CY; Huang, HW; Chen, SC; Hong, CF; Lin, RK; Chao, YS; Hsu, JTA |
| 國家衛生研究院 |
2004-07 |
Drug design for BPR0L075 as an anticancer agent
|
Hsieh, HP;Liou, JP;W., CC;Kuo, CC;Chang, YL;Kuo, FM;Tseng, HY;Pan, WY;Chen, CP;Yang, YN;Chen, CT;Lee, SJ;Chang, JY |
| 國立臺灣海洋大學 |
2004-07 |
Inhibition of SARS-CoV replication by niclosamide
|
Wu CJ1; Jan JT; Chen CM; Hsieh HP; Hwang DR; Liu HW; Liu CY; Huang HW; Chen SC; Hong CF; Lin RK; Chao YS; Hsu JT |
| 國家衛生研究院 |
2004-05-20 |
Synthesis and structure-activity relationships of 3-aminobenzophenones as antimitotic agents
|
Liou, JP; Chang, JY; Chang, CW; Chang, CY; Mahindroo, N; Kuo, FM; Hsieh, HP |
| 國家衛生研究院 |
2003-12-01 |
Substituent effects on di-pi-methane and aza-di-pi-methane rearrangements of dibenzo[f,h]quinoxalinobarrelenes
|
Lin, SY; Hsieh, HP; Peddinti, RK; Liao, CC |
| 國家衛生研究院 |
2003-06-15 |
Dual inhibition of topoisomerase I and tubulin polymerization by BPR0Y007, a novel cytotoxic agent
|
Chang, JY; Hsieh, HP; Pan, WY; Liou, JP; Bey, SJ; Chen, LT; Liu, JF; Song, JS |
| 國家衛生研究院 |
2003-03-10 |
Structure-activity and crystallographic analysis of benzophenone derivatives - the potential anticancer agents (vol 13, pg 101, 2003)
|
Hsieh, HP; Liou, JP; Lin, YT; Mahindroo, N; Chang, JY; Yang, YN; Chern, SS; Tan, UK; Chang, CW; Chen, TW; Lin, CH; Chang, YY; Wang, CC |
| 國家衛生研究院 |
2003-01-06 |
Structure-activity and crystallographic analysis of benzophenone derivatives - the potential anticancer agents
|
Hsieh, HP; Liou, JP; Lin, YT; Mahindroo, N; Chang, JY; Yang, YN; Chern, SS; Tan, UK; Chang, CW; Chen, TW; Lin, CH; Chang, YY; Wang, CC |
| 國家衛生研究院 |
2003 |
The synthetic 1-aroylindoles and 3-aroylindoles derivatives, combretastatin A-4 analogues, as a novel class of potent anticancer agents
|
Liou, JP;Chang, YL;Kao, FM;Chang, CW;Tseng, HY;Wang, CC;Yang, YN;J., LS;Hsieh, HP |
| 國家衛生研究院 |
2002-08 |
Synthesis and structure-activity relationship of 2-aminobenzophenone derivatives as antimitotic agents
|
Hsieh, HP;Liou, JP;Chang, CW;Song, JS;Yang, YN;Yeh, CF;Tseng, HY;Lo, YK;Chang, YL |
| 國家衛生研究院 |
2002-06-06 |
Synthesis and structure-activity relationship of 2-aminobenzophenone derivatives as antimitotic agents
|
Liou, JP; Chang, CW; Song, JS; Yang, YN; Yeh, CF; Tseng, HY; Lo, YK; Chang, YL; Chang, CM; Hsieh, HP |
顯示項目 241-265 / 265 (共6頁)
<< < 1 2 3 4 5 6 > >>
每頁顯示[10|25|50]項目
|
